SCHEMBL3758134

SCHEMBL3758134

C#Cc1ccc(OCCCCCCCCCCCC)c(OCCCCCCCCCCCC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHUK O15111 1/20 0.44
DAPK3 O43293 1/20 0.44
JAK2 O60674 1/20 0.44
ROCK2 O75116 1/20 0.44
PRKCG P05129 1/20 0.44
CDK1 P06493 1/20 0.44
PIM1 P11309 1/20 0.44
RPS6KB1 P23443 1/20 0.44
CDK2 P24941 1/20 0.44
AKT1 P31749 1/20 0.44
AKT2 P31751 1/20 0.44
MAPKAPK2 P49137 1/20 0.44
BLK P51451 1/20 0.44
RPS6KA3 P51812 1/20 0.44
JAK3 P52333 1/20 0.44
LIMK1 P53667 1/20 0.44
PRKCZ Q05513 1/20 0.44
PRKCD Q05655 1/20 0.44
PAK1 Q13153 1/20 0.44
STK3 Q13188 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29607397 1.00 CHUK (0.44) CHUKDAPK3JAK2ROCK2PRKCG
SCHEMBL28748440 1.00 CHUK (0.44) CHUKDAPK3JAK2ROCK2PRKCG
SCHEMBL7925295 0.93 CYP1A2 (0.41) CHUKDAPK3JAK2ROCK2PRKCG
SCHEMBL29101743 0.90 SMPD1 (0.50) CHUKDAPK3JAK2ROCK2PRKCG
SCHEMBL28041717 0.87 ALDH1A1 (0.45) CHUKDAPK3JAK2ROCK2PRKCG
SCHEMBL2851634 0.87 ALDH1A1 (0.48) CHUKDAPK3JAK2ROCK2PRKCG
SCHEMBL9710334 0.86 THRA (0.48) CHUKDAPK3JAK2ROCK2PRKCG
SCHEMBL9710151 0.86 THRA (0.48) CHUKDAPK3JAK2ROCK2PRKCG
SCHEMBL9850712 0.86 THRA (0.48) CHUKDAPK3JAK2ROCK2PRKCG
SCHEMBL8751862 0.86 THRA (0.48) CHUKDAPK3JAK2ROCK2PRKCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200290980-A1 POLYCATENAR LIGANDS AND HYBRID NANOPARTICLES MADE THEREFROM CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2020-09-17 US disclosed
US-7842830-B2 Transition-metal charge-transport materials, methods of fabrication thereof, and methods of use thereof GEORGIA TECH RESEARCH CORPORATION (US) 2010-11-30 US disclosed
US-7842830-B2 Transition-metal charge-transport materials, methods of fabrication thereof, and methods of use thereof GEORGIA TECH RESEARCH CORPORATION (US) 2010-11-30 US disclosed
US-20080121870-A1 Transition-Metal Charge Transport Materials, Methods Of Fabrication Thereof, And Methods Of Use Thereof GEORGIA TECH RESEACH CORPORATION 2008-05-29 US disclosed
US-20080121870-A1 Transition-Metal Charge Transport Materials, Methods Of Fabrication Thereof, And Methods Of Use Thereof GEORGIA TECH RESEACH CORPORATION 2008-05-29 US disclosed
WO-2005123754-A2 TRANSITION-METAL CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2005-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200290980-A1 POLYCATENAR LIGANDS AND HYBRID NANOPARTICLES MADE THEREFROM PICALM, CD63, EPCAM CHUK 4583/4885DAPK3 2987/4885JAK2 1899/4885
US-20080121870-A1 Transition-Metal Charge Transport Materials, Methods Of Fabrication Thereof, And Methods Of Use Thereof SLC39A3, SLC6A6, SLC6A9 CHUK 4884/4885DAPK3 3270/4885JAK2 3418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.